Tyr-OVA (257-264), YSIINFEKL is an antigenic variant peptide used to explore residue-driven recognition in immunological binding systems. The N-terminal aromatic substitution allows spectroscopic tracking and structural analysis. Its sequence supports investigations of peptide–protein docking. Researchers apply it in molecular mapping of presentation motifs.
CAT No: O05026
4. Cationic cell-penetrating peptides are potent furin inhibitors
5. Implications of ligand-receptor binding kinetics on GLP-1R signalling
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.